Literature DB >> 34117856

Establishment of risk prediction nomogram for ipsilateral axillary lymph node metastasis in T1 breast cancer.

Yuanyuan Fu1, Jingxin Jiang1, Shuzheng Chen1, Fuming Qiu1.   

Abstract

:To establish and verify a risk prediction nomogram for ipsilateral axillary lymph node metastasis in breast cancer stage T1 (mass ≤ 2 cm). :The clinicopathological data of 907 patients with T1 breast cancer who underwent surgical treatment from January 2010 to June 2015 were collected,including 573 cases from the Second Affiliated Hospital of Zhejiang University School of Medicine (modeling group) and 334 cases from Zhejiang University Lishui Hospital (verification group). The risk factors of ipsilateral axillary lymph node metastasis were analyzed by univariate and multivariate logistic regression. The influencing factors were used to establish a nomogram for predicting ipsilateral axillary lymph nodes metastasis in T1 breast cancer. The model calibration,predictive ability and clinical benefit in the modeling group and the verification group were analyzed by C index,receiver operating characteristic curve,calibration curve and decision curve analysis (DCA) curve,respectively. :Univariate analysis showed that lymph node metastasis was related with primary tumor size,vascular tumor thrombus,Ki-67,histopathological grade,and molecular type (<0.05 or <0.01). Multivariate logistic regression analysis showed that the primary tumor > vascular tumor thrombus,Ki-67 positive,estrogen receptor (ER) positive,and histopathological grade 2-3 were independent risk factors of axillary lymph node metastasis (<0.05 or <0.01). Based on the independent risk factors,a nomogram prediction model was established. The C indexes of the model group and the validation group were 0.739 (95%:0.693-0.785) and 0.736 (95%:0.678-0.793),respectively. The calibration curve and DCA curve of the modeling group and the verification group indicated that the model was consistent and had good clinical benefit. :Primary tumor size,histopathological grade,vascular tumor thrombus,Ki-67,and ER status are predictors of ipsilateral axillary lymph node metastasis in T1 breast cancer. The established prediction nomogram can effectively predict the risk of ipsilateral axillary lymph node metastasis in T1 breast cancer,which can be used as a reference for individualized axillary management.

Entities:  

Keywords:  Breast neoplasm; Lymphatic metastasis; Nomogram; Prediction; Risk factors

Mesh:

Year:  2021        PMID: 34117856      PMCID: PMC8675074          DOI: 10.3724/zdxbyxb-2021-0013

Source DB:  PubMed          Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban        ISSN: 1008-9292


  25 in total

1.  Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015.

Authors:  A S Coates; E P Winer; A Goldhirsch; R D Gelber; M Gnant; M Piccart-Gebhart; B Thürlimann; H-J Senn
Journal:  Ann Oncol       Date:  2015-05-04       Impact factor: 32.976

2.  [Histological grading of invasive breast carcinoma: Nottingham histological grading system].

Authors:  F Mei; J Y Liu; W C Xue
Journal:  Zhonghua Bing Li Xue Za Zhi       Date:  2019-08-08

3.  Two decades of axillary management in breast cancer.

Authors:  M A Beek; N C Verheuvel; E J T Luiten; E G Klompenhouwer; H J T Rutten; R M H Roumen; P D Gobardhan; A C Voogd
Journal:  Br J Surg       Date:  2015-12       Impact factor: 6.939

4.  Validation and update of a lymph node metastasis prediction model for breast cancer.

Authors:  Si-Qi Qiu; Merel Aarnink; Marissa C van Maaren; Monique D Dorrius; Arkajyoti Bhattacharya; Jeroen Veltman; Caroline A H Klazen; Jan H Korte; Susanne H Estourgie; Pieter Ott; Wendy Kelder; Huan-Cheng Zeng; Hendrik Koffijberg; Guo-Jun Zhang; Gooitzen M van Dam; Sabine Siesling
Journal:  Eur J Surg Oncol       Date:  2018-01-17       Impact factor: 4.424

5.  Predictive factors of isolated tumor cells and micrometastases in axillary lymph nodes in breast cancer.

Authors:  Eva V E Madsen; Sjoerd G Elias; Thijs van Dalen; Pouline M P van Oort; Joost van Gorp; Paul D Gobardhan; Vivian Bongers
Journal:  Breast       Date:  2013-01-10       Impact factor: 4.380

6.  Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.

Authors:  Armando E Giuliano; Karla V Ballman; Linda McCall; Peter D Beitsch; Meghan B Brennan; Pond R Kelemen; David W Ollila; Nora M Hansen; Pat W Whitworth; Peter W Blumencranz; A Marilyn Leitch; Sukamal Saha; Kelly K Hunt; Monica Morrow
Journal:  JAMA       Date:  2017-09-12       Impact factor: 56.272

7.  Risk Stratification For Axillary Lymph Node Metastases in Breast Cancer Patients: What Clinicopathological and Radiological Factors of Primary Breast Cancer Can Predict Preoperatively Axillary Lymph Node Metastases?

Authors:  Seong Jong Yun; Yu-Mee Sohn; Mirinae Seo
Journal:  Ultrasound Q       Date:  2017-03       Impact factor: 1.657

8.  Basal breast cancer molecular subtype predicts for lower incidence of axillary lymph node metastases in primary breast cancer.

Authors:  Simon J Crabb; Maggie C U Cheang; Samuel Leung; Taina Immonen; Torsten O Nielsen; David D Huntsman; Chris D Bajdik; Stephen K Chia
Journal:  Clin Breast Cancer       Date:  2008-06       Impact factor: 3.225

9.  The role of VEGF-C/D and Flt-4 in the lymphatic metastasis of early-stage invasive cervical carcinoma.

Authors:  Hao Yu; Shiqian Zhang; Renhua Zhang; Linlin Zhang
Journal:  J Exp Clin Cancer Res       Date:  2009-07-09

10.  Tumor characteristics of breast cancer in predicting axillary lymph node metastasis.

Authors:  Hsin-Shun Tseng; Li-Sheng Chen; Shou-Jen Kuo; Shou-Tung Chen; Yu-Fen Wang; Dar-Ren Chen
Journal:  Med Sci Monit       Date:  2014-07-07
View more
  1 in total

1.  The NILS Study Protocol: A Retrospective Validation Study of an Artificial Neural Network Based Preoperative Decision-Making Tool for Noninvasive Lymph Node Staging in Women with Primary Breast Cancer (ISRCTN14341750).

Authors:  Ida Skarping; Looket Dihge; Pär-Ola Bendahl; Linnea Huss; Julia Ellbrant; Mattias Ohlsson; Lisa Rydén
Journal:  Diagnostics (Basel)       Date:  2022-02-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.